Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.

<h4>Introduction</h4>This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin sensitivity in ICU patients based on diagnosis and day of stay.<h4>Materials and methods</h4>An analysis of model-based insulin sensitivity for n=...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tamás Ferenci, Balázs Benyó, Levente Kovács, Liam Fisk, Geoffrey M Shaw, J Geoffrey Chase
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/886abae87a2e4d039fa71edda83717d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:886abae87a2e4d039fa71edda83717d8
record_format dspace
spelling oai:doaj.org-article:886abae87a2e4d039fa71edda83717d82021-11-18T07:56:31ZDaily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.1932-620310.1371/journal.pone.0057119https://doaj.org/article/886abae87a2e4d039fa71edda83717d82013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23437328/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Introduction</h4>This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin sensitivity in ICU patients based on diagnosis and day of stay.<h4>Materials and methods</h4>An analysis of model-based insulin sensitivity for n=390 patients in a medical ICU (Christchurch, New Zealand). Two metrics are defined to measure the variability of a patient's insulin sensitivity relative to predictions of a stochastic model created from the same data for all patients over all days of stay. The first selectively captures large increases related to the risk of hypoglycemia. The second captures overall variability. Distributions of per-patient variability scores were evaluated over different ICU days of stay and for different diagnosis groups based on APACHE III: operative and non-operative cardiac, gastric, all other. Linear and generalized linear mixed effects models assess the statistical significance of differences between groups and over days.<h4>Results</h4>Variability defined by the two metrics was not substantially different. Variability was highest on day 1, and decreased over time (p<0.0001) in every diagnosis group. There were significant differences between some diagnosis groups: non-operative gastric patients were the least variable, while cardiac (operative and non-operative) patients exhibited the highest variability.<h4>Conclusions</h4>This study characterizes the variability and evolution of insulin sensitivity in critically ill patients, and may help inform the clinical management of metabolic dysfunction in critical care.Tamás FerenciBalázs BenyóLevente KovácsLiam FiskGeoffrey M ShawJ Geoffrey ChasePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 2, p e57119 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tamás Ferenci
Balázs Benyó
Levente Kovács
Liam Fisk
Geoffrey M Shaw
J Geoffrey Chase
Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
description <h4>Introduction</h4>This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin sensitivity in ICU patients based on diagnosis and day of stay.<h4>Materials and methods</h4>An analysis of model-based insulin sensitivity for n=390 patients in a medical ICU (Christchurch, New Zealand). Two metrics are defined to measure the variability of a patient's insulin sensitivity relative to predictions of a stochastic model created from the same data for all patients over all days of stay. The first selectively captures large increases related to the risk of hypoglycemia. The second captures overall variability. Distributions of per-patient variability scores were evaluated over different ICU days of stay and for different diagnosis groups based on APACHE III: operative and non-operative cardiac, gastric, all other. Linear and generalized linear mixed effects models assess the statistical significance of differences between groups and over days.<h4>Results</h4>Variability defined by the two metrics was not substantially different. Variability was highest on day 1, and decreased over time (p<0.0001) in every diagnosis group. There were significant differences between some diagnosis groups: non-operative gastric patients were the least variable, while cardiac (operative and non-operative) patients exhibited the highest variability.<h4>Conclusions</h4>This study characterizes the variability and evolution of insulin sensitivity in critically ill patients, and may help inform the clinical management of metabolic dysfunction in critical care.
format article
author Tamás Ferenci
Balázs Benyó
Levente Kovács
Liam Fisk
Geoffrey M Shaw
J Geoffrey Chase
author_facet Tamás Ferenci
Balázs Benyó
Levente Kovács
Liam Fisk
Geoffrey M Shaw
J Geoffrey Chase
author_sort Tamás Ferenci
title Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
title_short Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
title_full Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
title_fullStr Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
title_full_unstemmed Daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
title_sort daily evolution of insulin sensitivity variability with respect to diagnosis in the critically ill.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/886abae87a2e4d039fa71edda83717d8
work_keys_str_mv AT tamasferenci dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
AT balazsbenyo dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
AT leventekovacs dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
AT liamfisk dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
AT geoffreymshaw dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
AT jgeoffreychase dailyevolutionofinsulinsensitivityvariabilitywithrespecttodiagnosisinthecriticallyill
_version_ 1718422742746791936